Abstract
Objectives This study investigates the role of and methods for patent analysis in advancing medical technology (MedTech) innovation, a sector characterized by diverse, non-pharmacological or non-immunological healthcare technologies and significant research investment. Patents are critical early indicators of innovation, supporting horizon scanning and weak signal detection. The study aimed to identify intellectual property sources, evaluate methods for patent retrieval and analysis, and outline objectives for using patent data to anticipate trends and inform healthcare strategies. It also offered a methodological framework to support stakeholders in adopting innovative MedTech solutions.
Methods A rapid review (RR) was conducted using Cochrane Rapid Review Methods and PRISMA guidelines, with a pre-registered protocol on the Open Science Framework. Searches in Embase, IEEE Xplore, and Web of Science targeted records from 2020 onwards. Three independent reviewers screened studies using Rayyan. We included any study type, published since 2020 that provided sufficient data on patent sources, methods and tools applied to the study of MedTech. Our data extraction included bibliographic details, study characteristics, and methodological information. Risk of bias assessments were not undertaken. Narrative and tabular methods, supplemented by visual charts, were employed to synthesise findings.
Results Our searches identified 1,741 studies, of which 124 were included after title, abstract, and full-text screening, with 54% being original research, 44% reviews, and the remainder being conference abstracts. Most studies (68%) relied solely on patent databases, while others searched the grey literature. Research objectives of the included studies were grouped into nine themes, with trend analysis (50%) and policy recommendations (20%) being the most common. The review analysed 199 patent databases, with 27% of studies using multiple sources. Time horizons for patent searches averaged 24.6 years, ranging from 1900 to 2019. Automated approaches, employed in 33% of studies, frequently utilised tools like Gephi for network visualization. Disease mapping, based on NICE classification, indicated that cancer (19%) and respiratory conditions (16%), particularly COVID-19, were key areas, while digital health dominated the "health and social care delivery" category.
Conclusions The review highlights the value of patent data in trend analysis and its broader role in shaping policies and research strategies. While patents provide crucial insights into emerging technologies, inconsistent de-duplication practices across studies pose a risk of data inflation, accentuating the need for transparency and rigour. Finally, this review emphasized the importance of data transformation and visualization in detecting emerging trends with Python and R being the most commonly used programming languages for developing custom tools.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study/project is funded by the National Institute for Health and Care Research (NIHR) (NIHRIO/project reference HSRIC-2016-10009).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript and supplementary materials.
